Application of Artificial Intelligence in Neurological Disorders (人工智慧在神經疾病中的應用)
Bhupathyraaj, Mullaicharam, Vijayarani, K. Reeta, Dhanasekaran, Muralikrishnan
相關主題
商品描述
This book discusses the role of artificial intelligence in neurological disorders, including, alleviating movement disorders, psychiatric disorders, diagnosis of neurological and neurodegenerative disorders, dementia, neuronal cancer, neuronal Infections, and brain diseases. It explores applications of artificial intelligence in the early diagnosis, prognosis, and development of new therapies against neurodegenerative disorders. This book also provides cutting-edge research using AI for studying neuroimage analysis, toward the discovery of new biological pathways and systems implicated in dementia and related diseases. It also reviews AI-based interventions in depression research and treatment. The chapter also examines the potential benefits of using AI to help manage depression, from improved access to coordinated care. This book is an essential source for students, researchers, academicians, and neurologists aiming to understand AI-based approaches for the diagnosis, treatment, and prevention of neurological disorders.
商品描述(中文翻譯)
本書探討人工智慧在神經系統疾病中的角色,包括緩解運動障礙、精神疾病、神經及神經退行性疾病的診斷、癡呆、神經癌、神經感染及腦部疾病。它探索人工智慧在神經退行性疾病早期診斷、預後及新療法開發中的應用。本書還提供了使用人工智慧進行神經影像分析的前沿研究,以發現與癡呆及相關疾病相關的新生物途徑和系統。它還回顧了基於人工智慧的抑鬱症研究和治療干預。本章還檢視了使用人工智慧幫助管理抑鬱症的潛在好處,包括改善協調護理的可及性。本書是學生、研究人員、學者及神經科醫生理解基於人工智慧的神經系統疾病診斷、治療及預防方法的重要資源。
作者簡介
Prof. Mullaicharam is a professor of pharmaceutics at the College of Pharmacy, National University of Science & Technology, Muscat, Sultanate of Oman. She has more than two decades of teaching and research experience and has received awards at the national and international levels. She received many research grants and has 9 international patents. Her research interests include biomedical, nano pharmaceuticals, herbal formulation development, and applications of AI. She has publications and patents in the field of artificial intelligence in medical imaging and has published various research articles in peer-reviewed journals, and several book chapters. She is also serving as an editorial board member and a reviewer in various peer-reviewed journals and presented many papers at various conferences. She has authored many textbooks (USA and Germany) and is a reviewer of several peer-reviewed journals. She is a registered pharmacist, in India and a life member of professional bodies of IPA, ( The Indian Pharmaceutical Association) APTI (Association of Pharmaceutical Teachers of India), IPGA (Indian Pharmacy Graduates Association), and ISTE (International Society for Technology in Education).
Prof. Reeta Vijaya Rani is a professor in the pharmaceutics department of Surya School of Pharmacy in Vikravandi, Villupuram, and a member of the Surya Group of Institutions. She has combined experience of 27 years in pharmaceutical research and education. She has authored and presented papers at both the national and international levels and is serving as an editorial board member and a reviewer in various peer-reviewed journals. She has extensive academic writing knowledge and experience. She has written and edited various chapters and textbooks on pharmaceutical science. Prof. Reeta also holds the achievement of securing Indian & German patents. Her key research interests are biodiversity and novel therapeutic techniques.
Prof. Muralikrishnan Dhanasekaran, Ph.D., is a professor in the department of drug discovery and development at Harrison School of Pharmacy, Auburn University, USA. He has more than 110 peer-reviewed international publications, and several book chapters, and is a reviewer of various peer-reviewed journals. Prof. Dhanasekaran's lab and research interests are in preclinical research and drug development in neuropharmacology. His current research involves elucidating the neuroprotective and neurotoxic effects of natural bioactive and synthetic compounds and discovering and developing drugs/compounds targeting epilepsy, alzheimer's disease, and parkinson's disease.
Prof. Musthafa Mohamed Essa, Ph.D., is a professor of nutrition at Sultan Qaboos University, Oman. He is an Editor-in-Chief for the International Journal of Nutrition, Pharmacology, Neurological Diseases. He is also acting as an associate editor for BMC complementary and alternative medicine and is an Editor for Frontiers in Neuroscience and Frontiers in Biosciences. Prof. Essa is an expert in the field of nutritional neuroscience/neuropharmacology and has published more than 182 papers, 60 book chapters, and 14 books. Prof. Essa is the recipient of several awards, including the best book in the world, National Research Award, Outstanding neuroscientist, and Distinguished Researcher. He has over 15 years of research and teaching experience in the field of nutritional neuroscience.
作者簡介(中文翻譯)
穆萊查拉姆教授是阿曼蘇丹國科學與技術大學藥學院的藥劑學教授。她擁有超過二十年的教學和研究經驗,並在國內外獲得多項獎項。她獲得了多項研究經費,並擁有9項國際專利。她的研究興趣包括生物醫學、納米藥物、草藥配方開發及人工智慧的應用。她在醫學影像的人工智慧領域發表了多篇論文和專利,並在同行評審的期刊上發表了多篇研究文章及數個書章。她同時擔任多個同行評審期刊的編輯委員會成員和審稿人,並在各種會議上發表了多篇論文。她著有多本教科書(美國和德國),並是幾本同行評審期刊的審稿人。她是印度的註冊藥劑師,並且是印度藥學會(IPA)、印度藥學教師協會(APTI)、印度藥學畢業生協會(IPGA)及國際教育技術學會(ISTE)的終身會員。
瑞塔·維賈·拉尼教授是維克拉萬迪的蘇利亞藥學院藥劑學系教授,也是蘇利亞機構集團的成員。她在藥物研究和教育方面擁有27年的綜合經驗。她在國內外發表和呈現過多篇論文,並擔任多個同行評審期刊的編輯委員會成員和審稿人。她在學術寫作方面擁有豐富的知識和經驗,撰寫和編輯過多個藥學科學的章節和教科書。瑞塔教授還獲得了印度和德國的專利。她的主要研究興趣是生物多樣性和新型治療技術。
穆拉利克里希南·達納塞卡蘭教授(Ph.D.)是美國奧本大學哈里森藥學院的藥物發現與開發系教授。他擁有超過110篇同行評審的國際出版物和數個書章,並是多個同行評審期刊的審稿人。達納塞卡蘭教授的實驗室和研究興趣集中在神經藥理學的前臨床研究和藥物開發上。他目前的研究涉及闡明天然生物活性和合成化合物的神經保護和神經毒性效應,以及發現和開發針對癲癇、阿茲海默症和帕金森病的藥物/化合物。
穆斯塔法·穆罕默德·埃薩教授(Ph.D.)是阿曼卡布斯蘇丹大學的營養學教授。他是《國際營養、藥理學和神經疾病期刊》的主編,並擔任BMC補充與替代醫學的副編輯,還是《前沿神經科學》和《前沿生物科學》的編輯。埃薩教授是營養神經科學/神經藥理學領域的專家,已發表超過182篇論文、60個書章和14本書籍。埃薩教授獲得多項獎項,包括世界最佳書籍、國家研究獎、傑出神經科學家和傑出研究者。他在營養神經科學領域擁有超過15年的研究和教學經驗。